Taking a more focused approach, we here intend to delve into the specific problem of lymphopenia in the oncology patient, first analyzing its major aspects and pathological consequences and then demonstrating how recombinant IL-7 represents a potentially effective therapy for treatment of this condition and a solution to a longstanding medical problem. This evidence concerns the gene IL7 and lymphopenia.